The structure of propranolol hemisuccinate

Area of Science:

• Pharmaceutical Chemistry
• Analytical Chemistry
• Organic Chemistry

Background:

• Propranolol conjugates are crucial for developing radioimmunoassays to quantify the drug.
• Previous studies incorrectly assigned an O-hemisuccinate structure to a key propranolol conjugate.
• Accurate structural identification is vital for reliable immunoassay development and drug monitoring.

Purpose of the Study:

• To definitively assign the chemical structure of the hemisuccinyl derivative of propranolol.
• To correct the previously reported O-hemisuccinate structure to the N-hemisuccinyl-N-isopropylamino structure.
• To provide accurate structural data for the synthesis of propranolol immunogens.

Main Methods:

• Reaction of propranolol with succinic anhydride under specific conditions (pyridine, 70°C, 5 hours).
• Analysis of the resulting conjugate using infrared (IR) spectroscopy.
• Characterization using nuclear magnetic resonance (NMR) spectroscopy.
• Comparison of spectral data with model compounds (O-acetylpropranolol, N-acetylpropranolol, N,O-diacetylpropranolol).

Main Results:

• The succinylation product of propranolol was identified as the N-hemisuccinyl-N-isopropylamino derivative, not the O-hemisuccinate.
• Spectral data (IR and NMR) confirmed the formation of an amide linkage.
• The presence of the N,O-dihemisuccinyl derivative as a minor contaminant was also noted.

Conclusions:

• The amide structure of the propranolol hemisuccinyl conjugate is confirmed through spectral analysis.
• This structural elucidation is critical for the accurate development of radioimmunoassay methods for propranolol.
• The findings necessitate a re-evaluation of previous work relying on the assumed O-hemisuccinate structure.